Ayrak Pharma LLP
About Ayrak Pharma LLP
Data last updated:
Ayrak Pharma LLP is a limited liability partnership (LLP) based in Nagpur, Maharashtra, India. It operates in the precision and optical instruments segment of the electronics sector. It was incorporated on 20 December 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Nagpur, under LLPIN AAR-3835.
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Omkar Sachin Mamidwar and Palash Dilip Gangamwar.
Its latest statement of accounts is for the year ended 31 March 2022. The registered office is at Flat No. 51 Flat No 47 Gawande Layout, Nagpur, Maharashtra, India – 440025.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat No. 51 Flat No 47 Gawande Layout, Nagpur, Maharashtra, India – 440025
- IndustryElectrnoics, Precision & Optical Instruments, Manufacturing, Medical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Ayrak Pharma LLP FY 2022 filings available
Financial Statement Summary of Ayrak Pharma LLP
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• |
| Assets and Liabilities | |||
| Partners' Contribution | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Ayrak Pharma LLP
| Statement of Account and Solvency | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Ayrak Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Ayrak Pharma LLP
Ayrak Pharma has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Omkar Sachin Mamidwar Also directs: GPM Spaces LLP, Aika Essentials LLP | Designated Partner | 20 Dec 2019 | 6 Years 9 Months | Current |
| Palash Dilip Gangamwar | Designated Partner | 20 Dec 2019 | 6 Years 9 Months | Current |
Charges & Borrowings of Ayrak Pharma LLP
Ayrak Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ayrak Pharma LLP
Employment history and EPFO contributions of people linked to Ayrak Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ayrak Pharma LLP
Ayrak Pharma LLP has 2 designated partner changes on record since 2019: 2 appointments. The latest: Omkar Sachin Mamidwar was appointed as Designated Partner on 20 Dec 2019.
Credit Ratings, Litigation & Regulatory Alerts for Ayrak Pharma LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ayrak Pharma LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ayrak Pharma LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ayrak Pharma LLP
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ayrak Pharma LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ayrak Pharma LLP
Ayrak Pharma is an active limited liability partnership based in Nagpur, Maharashtra, India. The LLP works in precision and optical instruments, within the electronics industry. It was incorporated on 20 December 2019 (7+ years old) and is registered under LLPIN AAR-3835.
Ayrak Pharma has 2 current designated partners:
- Omkar Sachin Mamidwar - Designated Partner
- Palash Dilip Gangamwar - Designated Partner
The LLPIN (Limited Liability Partnership Identification Number) of Ayrak Pharma is AAR-3835. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Ayrak Pharma was incorporated on 20 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Nagpur.
Omkar Sachin Mamidwar was appointed as Designated Partner on 20 Dec 2019. Palash Dilip Gangamwar was appointed as Designated Partner on 20 Dec 2019.
The registered office of Ayrak Pharma is at Flat No. 51 Flat No 47 Gawande Layout, Nagpur, Maharashtra, India – 440025.
The total obligation of contribution is ₹1 Lakh.
Ayrak Pharma operates in the electronics industry, in the precision and optical instruments segment.
Ayrak Pharma can be reached at its registered office: Flat No. 51 Flat No 47 Gawande Layout, Nagpur, Maharashtra, India – 440025.
Ayrak Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Nagpur.